Latest Strategic Placements News

Alvo Minerals has raised A$1.25 million through a premium-priced placement to strategic investors, bolstering its exploration efforts at key critical minerals projects in Brazil, including the Palma copper-zinc resource and rare earth element targets.

Freehill Mining’s aggregates business surged with a 59% jump in quarterly sales, while new copper project options promise to shift the company’s growth trajectory.

Aurum Resources has boosted its total gold resources to 4.2 million ounces across two Côte d’Ivoire projects, supported by ongoing drilling and a strategic placement led by Perseus Mining. The company’s strong cash position and board strengthening set the stage for upcoming feasibility milestones.

FortifAI’s Nol8 FPGA appliance dramatically reduces AI infrastructure costs by replacing up to 60,000 CPUs, slashing annual operational expenses from millions to tens of thousands of dollars.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Altair Minerals has landed a A$28.2 million strategic placement from Endeavour Mining’s subsidiary at a premium, boosting its treasury to about A$40 million and enabling a major expansion of exploration at the Greater Oko gold project in Guyana.

Basin Energy secures A$1.1 million through a strategic placement led by two uranium-sector investors, aiming to accelerate drilling and geophysics at its Sybella Barkly and Newmans projects in Queensland.

Elementos Limited has made significant strides in developing its tin and tungsten assets, with progress on Oropesa’s permitting and a major resource upgrade at Cleveland. A $29.5 million strategic placement bolsters its balance sheet for upcoming milestones.

Cambium Bio has secured FDA confirmation that a single pivotal Phase 3 trial plus confirmatory evidence will suffice for Biologics License Application submission for Elate Ocular, significantly reducing development expenses and accelerating the pathway to market.

BPM Minerals has reported compelling high-grade gold assay results from maiden drilling at its Beachcomber Prospect and secured A$3.5 million in a strategic placement to fund an expanded 2026 exploration campaign across its Forelands Gold Project.

Xstate Resources has kicked off the stimulation program at its Diona-1 gas well in Queensland and raised $1.69 million through a strategic placement to fund next steps including pipeline connection and extended testing.